HIV is a dangerous infection that can significantly impact a person’s life, and if left unchecked, it can lead to the fatal disease known as AIDS. To prevent HIV, individuals must take daily medication and periodic injections. However, recent research brings a hopeful breakthrough. A new clinical trial has revealed that an injection can effectively protect against HIV, and it only needs to be administered once a year.

According to a BBC report, this new injection, called Lenacapavir, has shown promising results in protecting against HIV for high-risk individuals. Currently, people must take daily pills or receive an injection every two months for protection. However, Lenacapavir, an intramuscular injection, has proven effective in clinical trials and remains in the body for at least 56 weeks. This new treatment is considered safe, with no side effects observed in the trials, and could be a vital option for HIV prevention. The study was published in the prestigious medical journal, The Lancet.